HIGHLIGHTS
- who: Arash Delavar from the Division of Control and Population Sciences, National Institute, National Institutes of Health, Rockville, MD, USA have published the research: Approaches for monitoring and treating cardiomyopathy among cancer survivors following anthracycline or thoracic radiation treatment, in the Journal: (JOURNAL)
- what: 50-54.9% LVEF group Survivors that fell into this category in the study had a median lowest LVEF of 52.5% (50.6-53.1) and a median time from diagnosis of 23.7 (15.5-31.0) years.
- how: The authors conducted a retrospective descriptive study of . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.